ABSTRACT − Delivery of therapeutic protein drugs is a hot issue in the clinical application, because protein drugs have low side effects and highly therapeutic effects compared with chemical drugs. Despite their prominent advantages, protein drugs have high risk for human therapy such as their easy degradation by proteolytic enzymes, renal filtration and immune response. Over the past few decades, a large number of polysaccharides as vehicles for the protein delivery system have been developed to overcome the problems. This review presents the studies on protein delivery based on polysaccharides used as stabilizer and vehicles comprising nano-or microspheres to overcome inherent limitations of therapeutic proteins.
Recent advances of therapeutic protein drugs have become hot issues in pharmaceutical industry (Marshall, 2001) . Protein drugs have been recognized as highly effective therapeutic agents in autoimmune diseases (Moreland et al., 1999) , tumors (Chen et al., 2001) , arthritis and chronic diseases because of low side effects compared with normally used chemical drugs. For these reasons, therapeutic protein drugs with biological functions and information were required in pharmaceutical and basic research fields. Moreover, the main protein substances comprising most pharmaceutical patents were expired or will be expired before and after 2015 years. Therefore, the protein drugs have extensively researched with the same ripple effect of the novel drug development while reducing their risks.
Despite remarkable development of protein drugs, many obstacles are still faced because of their high cost regarding multi-step processing and their inherent disadvantages, such as short circulatory half-life and low stability (Chen et al., 1995; Sinha et al., 2003) . To overcome the problems, various stabilizers have been employed and the size-regulated protein delivery system was suggested, e.g. micro-size depot forms for long-term delivery (Crotts et al., 1998) , and nano size forms for site specific via systemic injection (Oh et al., 2010) . Various polymers, such as polysaccharides, poly(acrylic acid) family, polypeptides, poly(ethylene glycol) (PEG), poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and poly(lactide-coglycolide) (PLGA) are used as stabilizers and/or vehicles for protein drugs in the protein delivery system. Among polymers, polysaccharides have been particularly outstanding in the protein delivery system, because of their unique advantages, such as non-toxic, biocompatible, and biodegradable properties. (Liu et al., 2008) Due to these prominent properties, many research groups have reported the polysaccharide-based protein drug delivery system. The chemical structures of usual polysaccharides are shown in Figure 1 .
In this review, we shall focus on polysaccharide-based protein delivery system such as protein stabilizers, based on micro, and nano size particle system or both combination system, and discuss the use of polysaccharides for the increased protein stability and long circulatory half-life of protein drugs.
Additives as protein stabilizers
Because proteins are susceptible to both internal and external environment, they should be protected during preparation and release from protein-loaded particulate system. Particularly, proteins can be highly affected by the acidic condition, in which proteins can be readily degraded by peptide bond hydrolysis and non-covalent aggregation. PLGA, approved by Food and Drug Administration (FDA), is well known as a vehicle in the protein delivery system, due to its excellent biocompatibility and biodegradability. However, the acylation reaction of proteins with the PLGA also accelerates protein denaturation. PLGA has often showed reduced bioactivity and structural degradations due to acidic environmental interior of PLGA-depot resulting from its degradation. These acids facilitate a further degradation of PLGA and impair the physiological properties of the labile protein embedded in the PLGA (Kang et al., 2002; Tracy et al., 1999) . Some research groups co-incorporated an antacid to neutralize this acidic microcli-J. Pharm. Invest., Vol. 41, No. 4 (2011) mate, thus stabilizing the proteins against degrading conditions. However, the results did not entirely solve the problems associated with protein stability while preparing microspheres and releasing proteins, because once degraded PLGA microspheres remain able to denature proteins over long incubation periods. Although cyclodextrins and non-ionic surfactants were used as protein stabilizers to prevent protein denaturation, their stabilizing effects on labile proteins proved inconsistent among various proteins (Sturesson et al., 2000; Wang et al., 1998; Wang et al., 1999) . Recently, polysaccharides have been extensively investigated as potential stabilizers. Of these, chondroitin sulfate (CsA), a member of the glycosaminoglycan (GAG) family and an acidic mucopolysaccharide found in cartilage, skin, corneas, and umbilical cords, has been identified as a potential stabilizer for long-term protein delivery (Lee et al., 2007a; Park et al., 2009b; Volpi et al., 2006) because it can form polyelectrolyte complexes with positively charged proteins. Lee et al. reported that CsA polyelectrolyte complexes showed excellent stability of proteins during preparation and release in PLGA microspheres (Lee et al., 2007a) . Insoluble lysozyme which is referred as the denatured protein remained in PLGA microsphere groups compared with that in CsA polyelectrolyte complex loaded microspheres during 27 days after injection ( Figure 2 ). Although CsA is an excellent candidate for long-term protein stabilization, it cannot form a complex with some proteins/peptides having a lower pI value, such as insulin (pI=5.5), because both CsA (pKa=1.9) also has negative charges at neutral pH. Thus, a system for the preparation of the complex between CsA and proteins/peptides was proposed in an acidic pH of 3 ( J. Pharm. Invest., Vol. 41, No. 4 (2011) plexes between CsA and insulin suppressed the denaturation in the O/W interface. Moreover, when polysaccharide embedded in PLGA microcapsules, the system increased encapsulation efficiency and enhanced the insulin stability from conformational change during its release period (Park et al., 2009b) .
Chitosan is a partially deacetylated polysaccharide obtained by alkaline treatment of chitin. Chitosan has been widely used in pharmaceutical and medical areas, due to its favorable biological properties such as biodegradability, biocompatibility, and low toxicity. Because pKa of amine groups in chitosan is 6.2, chitosan at neutral pH hardly carries a charge, has a low solubility and is therefore essentially inactive (Mao et al., 2004) . Thus, various chemically modified chitosan derivatives have been synthesized and studied for different applications due to the presence of functional groups such as amine and hydroxyl moieties. Glycol chitosan (GC), a chitosan derivative conjugated with glycol, is soluble in water at a neutral/acidic pH and is viscous. This property can help formulate protein drugs and cells at neutral pH, without acids presence, and even hydrophobic drugs (Calvo et al., 1997; Jiang et al., 2005) . For example, GC was used as a nanocomplex carrier or protection material of cells or drugs in the anionic polymers from the host immune response Kim et al., 2006; Sakai et al., 2000) . For these reasons, GC could be employed as a potential stabilizer for preparing protein-loaded particles. Lysozymes are used as a model protein, because it is a primary enzyme responsible for chitosan degradation (Di Martino et al., 2005) . Lee et al. reported GC as a lysozyme stabilizer, which can be incorporated into PLGA microparticles, by using the multi-emulsion water-in-oil-in-water (W/O/W) method, because GC help reduce lysozyme denaturation at the O/W interface. Lysozyme hydrolyzes GC and then might produce reactive small molecules (fragmented GCs) during the incubation, and highly mobile small molecules of GCs would interact with the acidic PLGA degradation products, consequently stabilizing proteins from the degrading environment (Lee et al., 2007b) .
Pullulan, a neutral polysaccharide, has been extensively investigated in the basic research field, because its biocompatibility, biodegradability, and high solubility even in organic solvent Ohya et al., 1998) . However, pullulan itself as a carrier has limitations in the drug or protein delivery system for long-term delivery due to its non-ionic property, resulting in inducing initial burst release. Therefore, chemically modified pullulan has been prepared and researched for various applications. For example, negatively charged succinylated pullulan can form an ionic complex with positively charged proteins, such as lysozyme (pI=9.3), via an ionic interaction. Addition of succinylated pullulan to lysozyme can construct poly electronic complexes. Succinylated pullulan led to increase encapsulation efficiency of lysozyme into PLGA microspheres and improved lysozyme stability during the release period. As a result, poly electronic complexes between succinylated pullulan and lysozyme induced long-term delivery in PLGA microspheres, because succinylated pullulan helps stabilize lysozyme at O/W interface (Kim et al., 2010a) .
Micro-depot system
In addition to maintenance of protein stability, control release of protein drugs is also important while prohibiting their initial burst release from the particulate system, because excessive burst is wasteful, in that protein drugs lost in the burst phase are not available for later release. Accordingly, the goal of most efforts to control burst release is to minimize or eliminate burst entirely. Over the past decades, various technologies for sustained-release have proposed PLGA or PLA microencapsules which include solvent evaporation (Bodmeier et al., 1987) , phase-separation (Ruiz et al., 1989) and spraydrying (Bodmeier et al., 1988) method. Although these methods showed improved release behaviors of proteins in the particulate system, there remain intrinsic problems such as low encapsulation efficiency and initial burst of proteins. Charged proteins with pI can form poly electric complexes with oppositely charged polymers, thus resulting in inducing controlled release of proteins in the particulate system. Particularly, biodegradable polysaccharides with opposite charges to proteins may be one of the best candidates as a helper for sustainedrelease of proteins. In addition, hydrophobic modified polysaccharides also can form aggregates with proteins by hydro- Dextran which is a water-soluble polysaccharide composed of repeated monomeric glucose units with a predominance of 1,6-linkages allows facile immobilization of bio-molecules through a variety of procedures including protein/peptide coupling reagents (Wang et al., 2011) . Franssen et al. reported dextran microspheres prepared by a water-in-water emulsion technique for controlled release of protein from enzymatically degradation (Franssen et al., 1999) . The hydrogels based on methacrylated dextran was prepared for protein delivery in their previous reports. The release could be controlled by the water content and the degree of substitution of the gels (Van Dijk-Wolthuis et al., 1997). The encapsulation efficiency of proteins exceeded readily 90% and the initial burst release could be reduced to 10% or less by optimizing the water content and the degree of methacrylate substitution. This report demonstrated that the degradation rate of the microspheres, proportional to the amount of dextranase present in the microspheres, can be used to modulate the release of an initially entrapped protein for prolonged periods. More recently, Wang et al. reported multilayer microspheres by using dextran worked as a linker between Fe 3 O 4 core and SnO 2 shell (Wang et al., 2011) .
In another example, acetylated pullulan was investigated for long-term delivery by hydrophobic interaction between proteins and its acetyl groups to endow the appropriate properties for microsphere preparation via the double-emulsion method (Yang et al., 2009 ). This group already reported that acelylated pullulan was used for protein delivery. Acetylated pullulan microspheres sustained long-term release of proteins while preventing initial burst behaviors. The release behaviors of protein in the acetylated pullulan microspheres were controlled by the degree of acetylation. High levels of acetylation effectively improved lysozyme release kinetics by reducing initial burst release and extending continuous release over a period of time. As a result, the long-term stability of proteins in the acetylated pullulan microsphers was maintained by hydrophobic interactions between proteins and acetyl groups in the microparticle system. This study showed different immune response between PLGA microspheres and acetylated pullulan microspheres via a number of neutrophils in subcutaneous tissue and moderate fibrosis below the muscle layer. The acetylated pullulan microspheres reduced immune response more than PLGA itself microspheres, because the degradation products of PLGA facilitate subsequent neutrophil activation as the steady functioning phagocytosis against certain materials with local inflammation. Acetylated pullulan microspheres harboring a lot of hydroxyl groups constructed higher hydrodynamic volume, leading to inducing lower immune response on the tissue (Figure 4) .
Alginate, an anionic polysaccharide composed of homopolymeric blocks of (1-4)-linked mannuronate and its C-5 L-guluronate residues, can be covalently linked together in different sequences or blocks. Alginate hydrogels are often favored due to their resemblance of natural extrcellular matrix (ECM) (Koczkur et al., 2007) and their excellent property as an immunoisolation barrier for cells. In drug delivery system, the alginate microspheres have their smooth surface and mechanically stable nature. Bowersock et al. reported that vaccine-containing alginate microspheres by oral delivery administration (Bowersock et al., 1996) clearly showed effective for oral vaccination in several animal species. Wang et al. reported silkcoated alginate microspheres for protein delivery (Wang et al., 2007) . A layer-by-layer assembly technique using silk fibroin has recently been reported their group . Silk-coated multiple layers by electrostatic interactions most likely were mediated by interactions with the alginate microspheres. And both diffusion barrier and stabilization effect provided by silk coating may attribute to the retardation of drug release. Nano & combination system Self-assembled nano-carriers have been reported in using polymeric nanoparticles for anticancer drugs, genes and proteins in delivery systems with a size in the range of 10~1000 nm (Mohanraj et al., 2007) . Self-assembled nano-carriers are formed by physically or chemically cross-linked polymer networks. Typical polymers composed of self-assembled nano-carrier were synthesized di-block or tri-block copolymers consisting of hydrophilic and hydrophobic blocks. This amphiphilic property was emerging as a new strategy to develop nanosize materials such as micelles and bilayer membranes (Whitesides et al., 1991) . The merit of nano-carriers in drug delivery system is to maintain high stability, to increase loading capacity, to control particle size, and to easily perform systemic injection. Also, bio-polymers used as nano-carriers could be chemically modified for the purpose of specifically functional carriers (Mohanraj et al.) such as nanocapsules, nanospheres, nanomicelles and nanodrugs (Jung et al., 2000; Pinto Reis et al., 2006) . Mohanraj et al. reported chitosan based nanoparicles for delivery of proteins by creating a new type of hydrophilic nanoparticles and by evaluating their efficacy for the incorporation and controlled release of an angiogenesis inhibitor, arginine-rich hexapeptide (Mohanraj et al.) . The release kinetics showed that the release rate is highly affected by the nature of the interactive forces between the associated proteins and the matrix materials. Harada et al. reported new concept emerged in block copolymer micelle formation in an aqueous medium (Harada et al., 1995) . This involves the spontaneous formation of polyelectrolyte complexes of macromolecular assembly prepared through electrostatic interaction in an aqueous medium. Polyelectrolyte complex systems have been widely used due to ability to prepare in aqueous solution via unique charge density of proteins. Na et al. reported stability and bioactivity of nanocomplexes ( Figure 5 ) between negatively charged hyaluronic acid and TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) (Na et al., 2008) . Although the structure of TRAIL was slightly affect by the complex formation, the active site of TRAIL was still capable of binding to the death receptor on the cancer cells. The pharmacokinetics in complexes was evaluated by using male Sprague-Dawley rat and the kinetics profile of TRAIL complexes showed more sustained release than that of natural TRAIL. Kim et al. reported polyelectrolyte complex systems between hyaluronic acid and PEG-TRAIL for treatment of rheumatoid arthritis and conformed biological activity in vivo (Kim et al., 2010b) . The in vivo bio-distribution and diffusion kinetics of the complexes were observed during 8 days using near infrared (NIR) fluorescence imaging technique via labeling Cy5.5 ( Figure 6 ). The ionic complexes were included to induce sustained release compared with protein alone. The therapeutic effects of the complexes were investigated after subcutaneous injection of the formulations into collagen induced arthritis (CIA) mice. Compared with mice injected with hyaluronic acid or PEG-TRAIL, those with complexes displayed a significant reduction in paw swelling, erythema, and joint rigidity.
Hydrophobic polymers composed of micro-carriers have the capability of yielding sustained drug release, but hydrophobicity of the polymers may induce unfolding of protein/peptide molecules, probably resulting in losing their biological activity after being loaded in and then released from the hydrophobic polymeric systems (Sluzky et al., 1991) . In contrast, the nanocarriers have the capability of controlling a variety of moieties and performing systemic injection, but have difficulty achiev- Figure 6 . In vivo non-invasive fluorescence imaging of Cy5.5-labeled PEG-TRAIL in athymic nude mice. J. Pharm. Invest., Vol. 41, No. 4 (2011) ing sustained drug release (Li et al., 1998) . To promote the advantages and overcome the disadvantages of both systems, Park et al. reported novel platform biomaterial based on PLGA microsphere that coated heparin nanoparticles (Figure 7) for treatment of neurological disorders and injuries by using growth factors (Park et al., 2009a) . The growth factors were immobilized by heparin and growth factor-loaded nanoparticles are capable of sustaining primary nerve cells and providing the necessary support that is critical for regeneration. In the past decades, Chug et al. showed growth factor-loaded hyaluronic acid hydrogels (Chung et al., 2008) , but these hyaluronic acid hydrogels were continuously exposed to media containing transforming growth factor-b (TGF-β) in vitro. Thus, this group reported hyaluronic acid hydrogels combining TGF-β-loaded alginate microspheres, resulting in forming composite carriers capable of helping retain growth factor bioactivity in the scaffold and to promote chondrogenesis of mesenchymal stem cells when implanted (Bian et al., 2011) .
Conclusions
Although numerous synthetic polymer-based drug carriers for protein delivery have been developed, many obstacles to their practical applications still exist such as unstable protein drugs in body. To overcome these problems, natural polymers such as polysaccharides are often considered as attractive substitutes because they have excellent properties in design of drug delivery system, and can relatively make protein drugs more stable, more biocompatible and more economical than synthetic polymers. So for polysaccharides have been widely used as stabilizers in nano-and micro depot system based on PLGA in therapeutic protein drug delivery. The future of success of therapeutic protein delivery system will be dependent on development of biocompatible drug carriers and their physicochemical analyses in polysaccharide-based system. Although many advances have been reported, many works still remain for efficient drug delivery as mentioned above right site and right time.
